Digital Journal

Diabetes Devices Market Expected to Reach USD 53.06 billion by 2030

0

Increasing Prevalence of Diabetes and Technological Advancements Drive Significant Growth in Diabetes Devices Market

According to SNS Insider, the Diabetes Devices Market size was valued at USD 29.1 billion in 2022 and is estimated to reach USD 53.06 billion by 2030 and grow at a CAGR of 7.8% during the forecast period of 2023-2030.

Diabetes Devices Market is experiencing a change in its current landscape as the rising prevalence of diabetes patients all around the world and the opportunities which are associated with them will be the factors which are bringing positive notes to the entire growth of the market. Key players operating in this market are constantly tracking the leading indicators which include the per capita spending, the rising number of patients, and how the patients are reacting to the solutions which are currently available in the market.

According to the survey conducted by NIH, which stated people suffering from diabetes will increase by 129.7% in the future. This will be the important factor which will be addressed by most of the players as the market’s potential is getting extended with the rising number of patients. 

Get Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3159

Diabetes Devices Market
Diabetes Devices Market

Market Analysis:  

The market opportunities lie within the rising number of innovations related to the Diabetes Devices Market and the overall attractiveness of the emerging marketplace. The overall adoption and the benefits which are been associated with the devices which are innovated and offered by the key players, are said to be the factors which will be driving the maximum growth for the companies regardless of the external adversities. Also, the market will be facing severe problems related to the prices of the devices. Also, the regulatory issues are creating barriers for the key players when it comes to getting approvals for the innovations.

Major Key Players Covered in Diabetes Devices Market Report:

  • Medtronic plc
  • Abbott Laboratories
  • Hoffmann-La-Ltd.
  • Bayer AG
  • Lifescan Inc.
  • B Braun Melsungen AG
  • Lifescan Inc.
  • Dexcom Inc.
  • Insulet Corporation
  • Ypsomed Holdings
  • Companion Medical
  • Sanofi
  • Valeritas Holding Inc
  • Novo Nordisk

Key Segments Covered in Report:

By Type

  • Blood Glucose Monitoring Devices
    • Self-monitoring Devices
      • Blood Glucose Meters
      • Testing Strips
      • Lancets
    • Continuous Glucose Monitoring Devices
      • Sensors
      • Transmitters
      • Receive
    • Insulin Delivery Devices
      • Insulin Pumps
      • Insulin Pens
      • Insulin Syringes
      • Insulin Jet Injectors

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others

By End-use

  • Hospitals
  • Homecare
  • Diagnostic Centers

Segment Analysis:

Diabetes Devices Market segmentation is analysed by dividing the segments by type, distribution channel, and by end-use. When we focus on the distribution channel, the online pharmacies will be gaining the maximum share during the forecasted period. In by type segment blood glucose monitoring devices will be the sub-segment which will have the highest share as the rising awareness and the benefits which are yielded from it will enhance the overall growth of the Diabetes Devices Market.

Check Discount on this Report: https://www.snsinsider.com/discount/3159

Regional Analysis:

The N.A. will be the region which will have the highest share, as the data extracted by SNS Insider explains U.S. will be the region which will hold a share of 80% in NA region. The factors which are driving the growth will be mostly related to the rising prevalence of diabetes among all types of ageing population. The rising ageing population trend in the U.S. is said to be the factor which will make the Diabetes Devices Market look attractive in terms of overall revenue generation. APAC will also be sharing a significant share as the key players operating in this market seem to be claiming the opportunities which the emerging economies of this market bring to life.

How does current macro-economic conditions will impact the overall growth of the Diabetes Devices Market?

When we look at the current scenario, the lessons from past economic turmoil will be always running through our minds. The economic slowdown thus will impact the decision making of the patients. SNS Insider analysts has observed a change in the buying patterns of the patients amidst of the economic slowdown. The insights analysed will pay an imperative role in deriving the steps for the incumbents and the new entrants operating in this market.

Key Takeaways:

  • The rising number of diabetes patients all around the world and the estimated future values will add great market potential in terms of values and volumes.
  • The rising awareness of the products offered by the companies is gaining high awareness rates among patients suffering from diabetes in emerging economies.
  • The rising threats related to data security can prove to be a factor which can obstruct the growth of the Diabetes Devices Market.

Recent Developments:

  • The rising partnerships among the key players improve the overall global reach and tap into the opportunities which are aligned with the wearable devices trend.
  • For instance, Abbott CamDiab and Ypsomed have announced a partnership to develop a product which monitors glucose levels.

Buy Diabetes Devices Market Report: https://www.snsinsider.com/checkout/3159

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com/



Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

ED

Pharma 4.0 Market Worth USD 39.60 billion by 2031 – SNS Insider

Previous article

IT Asset Management (ITAM) Software Market Growth Propelled by Rising Need for Efficient Inventory Management

Next article

You may also like

Comments

Comments are closed.